Andreas G. Prentakis

Athens, ESYE31 12462, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Non-Pharmacological Interventions for Managing Apathy in Older Adults with Neurocognitive Disorders: A Systematic Review of Randomized Controlled Trials.

Non-Pharmacological Interventions for Managing Apathy in Older Adults with Neurocognitive Disorders: A Systematic Review of Randomized Controlled Trials.

Journal: Brain sciences

Published: April 24, 2026

Behavioural Cardiology: A Review on an Expanding Field of Cardiology-Holistic Approach.

Behavioural Cardiology: A Review on an Expanding Field of Cardiology-Holistic Approach.

Journal: Journal of personalized medicine

Published: June 26, 2025

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study.

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study.

Journal: Journal of Parkinson's disease

Published: July 10, 2023

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report.

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report.

Journal: Medicina (Kaunas, Lithuania)

Published: May 28, 2023

Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.

Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.

Journal: Parkinsonism & related disorders

Published: April 28, 2021

Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.

Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.

Journal: Journal of Parkinson's disease

Published: March 08, 2021

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.

Journal: Parkinsonism & related disorders

Published: August 06, 2020

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.

Journal: Journal of Parkinson's disease

Published: March 17, 2020

DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.

DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.

Journal: Parkinsonism & related disorders

Published: August 26, 2019

123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.

123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 05, 2017

Education, training, and professional issues of radiographers in six European countries: a comparative review.

Education, training, and professional issues of radiographers in six European countries: a comparative review.

Journal: Journal of European CME

Published: January 24, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026